Amanote Research
Register
Sign In
A Dendritic Cell-Derived Receptor Counteracts Antitumor Immunity
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2012-123
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 9, 2012
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Natural Killer Cells Recruit Dendritic Cells to Promote Antitumor Immunity
Cancer Discovery
Oncology
Absence of Scavenger Receptor a Promotes Dendritic Cell-Mediated Cross-Presentation of Cell-Associated Antigen and Antitumor Immune Response
Immunology and Cell Biology
Allergy
Immunology
Cell Biology
Toll-Like Receptor Triggering and T-Cell Costimulation Induce Potent Antitumor Immunity in Mice
Clinical Cancer Research
Cancer Research
Oncology
Dendritic Cells Combined With Tumor Cells and Α-Galactosylceramide Induce a Potent, Therapeutic and NK-cell Dependent Antitumor Immunity in B Cell Lymphoma
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Dendritic Cells as Adjuvants for Class I Major Histocompatibility Complex-Restricted Antitumor Immunity
Journal of Experimental Medicine
Medicine
Allergy
Immunology
Reprogramming Antitumor Immunity
Trends in Immunology
Allergy
Immunology
Effective Antitumor Immunity Against Murine Gliomas Using Dendritic Cells Transduced With hTERTC27 Recombinant Adenovirus
Oncology Reports
Medicine
Cancer Research
Oncology
Catechins and Antitumor Immunity
OncoImmunology
Oncology
Allergy
Immunology
Antiviral- And Antitumor-Specific T-Cell Immunity Is WDFY4-Dependent
Cancer Discovery
Oncology